#qidp

[amcrasto]

FDA approves new drug Aemcolo (rifamycin), to treat travelers’ diarrhea

FDA approves new drug Aemcolo (rifamycin), to treat travelers’ diarrhea

FDA approves new drug to treat travelers’ diarrheaThe U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool. “Travelers’ diarrhea affects millions of people each year and having…

View On WordPress

[amcrasto]

MK 7655, RELEBACTAM, a β-Lactamase inhibitor

MK 7655, RELEBACTAM, a β-Lactamase inhibitor

MK 7655, RELEBACTAM (1R,2S,5R)-7-Oxo-N-(4-piperidinyl)-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide (1R,2S,5R)-7-oxo-2-((piperidin-4-yl)carbamoyl)-1,6-diazabicyclo(3.2.1)octan-6-yl hydrogen sulfate monohydrate Sulfuric acid, mono((1R,2S,5R)-7-oxo-2-((4-piperidinylamino)carbonyl)-1,6-diazabicyclo(3.2.1)oct-6-yl) ester, hydrate (1:1) MF C12H22N4O7S MW 366.39068 g/mol CAS 1174020-13-3…

View On WordPress

[amcrasto]

WCK 5222, Wockhardt receives QIDP status for its new drug WCK 5222 from USFDA

WCK 5222, Wockhardt receives QIDP status for its new drug WCK 5222 from USFDA

  WCK 5222 Watch this post as I get to the structure………….. DEC2015 Wockhardt has received Qualified Infectious Disease Product (QIDP) status for its new drug WCK 5222,  a product from its breakthrough New Drug Discovery program in Anti Infectives from the US Food and Drug Administration (FDA). This is the fourth product from the company to receive this coveted status. During last year, the…

View On WordPress

[amcrasto]

Levonadifloxacin arginine salt, WCK 771

Levonadifloxacin arginine salt, WCK 771

 STEREOCENTERS SHOWN Levonadifloxacin arginine salt, WCK 771 S-(−)-9-Fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic Acid l-Arginine Salt Tetrahydrate RN: 306748-89-0

C19-H21-F-N2-O4.C6-H14-N4-O2

MW: 534.5855

L-Arginine, mono((5S)-9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylate)

View On WordPress

[amcrasto]

Levonadifloxacin arginine salt, WCK 771

Levonadifloxacin arginine salt, WCK 771

 STEREOCENTERS SHOWN Levonadifloxacin arginine salt, WCK 771 S-(−)-9-Fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic Acid l-Arginine Salt Tetrahydrate RN: 306748-89-0

C19-H21-F-N2-O4.C6-H14-N4-O2

MW: 534.5855

L-Arginine, mono((5S)-9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylate)

View On WordPress

[amcrasto]

USFDA grants Qualified Infectious Disease Product status to two Wockhardt drugs

USFDA grants Qualified Infectious Disease Product status to two Wockhardt drugs

      31 Aug, 2014, NEW DELHI: Drug maker WockhardtBSE -1.83 % today said that two of its anti-infective drugs have received Qualified Infectious Disease Product (QIDP) status from the US health regulator.Two drugs – WCK 771 and WCK 2349 – have received QIDP status, which allows fast-track review of the drug application by the US Food and Drug Administration (USFDA), Wockhardt said in a statement.…

View On WordPress

[amcrasto]

Radezolid in phase 2,Rib-X Pharmaceuticals

Radezolid

Radezolid

869884-78-6 cas no

http://www.ama-assn.org/resources/doc/usan/radezolid.pdf

869884-78-6, RX-103, RX-1741, RX-O1_667, Radezolid (USAN/INN),  UNII-53PC6LO35W Molecular Formula: C22H23FN6O3   Molecular Weight: 438.454823

Rib-X Pharmaceuticals

Phase II completed

N-{[(5S)-3-(2-fluoro-4′-{[(1H-1,2,3-triazol-5-ylmethyl)amino]methyl}biphenyl-4-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide

Rib…

View On WordPress

[amcrasto]

FINAFLOXACIN IN PHASE II for the treatment of ear infections

FINAFLOXACIN

FINAFLOXACIN

(S-cyano-1-cyclopropyl-ό-fluoro-T-^aS, 7aS)-hexahydropyrrolo [3,4- b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid)

7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid |

BAY-35-3377 BY-377

CAS Registry Number: 209342-40-5

HYD SALT

(-)-(4aS,7aS)-8-Cyano-1-cyclopropyl-6-fluoro-4-ox…

View On WordPress